Verified Companies
Secure Payment
Legally Binding
MariamTek
MariamTek finds profitable solutions for the biggest problems in healthcare and the environment.
Revenue sources
Biotech
Environmental
Technology Licensing
Regional Licensing
$20
Price
10%
Royalty
50,000
TOTAL UNITS
MariamTek finds profitable solutions for the biggest problems in healthcare and the environment
Biotechnology and environmental solutions that make an impact and profit
The team is headed by physician-surgeon and research scientist Dr. Mark Holterman, MD-PhD
Biomedical
During this past year Mariamtek spun off DiabetesActual as a free standing ILOCX listing dedicated to growing its existing Diabetes Actual clinics in the US as well as similar clinics in the Middle East and South and SE Asia. https://listing.ilocx.com/dba
Cardiology Institute of America - MariamTek is proud to announce the acquisition of this revenue-positive company that provides diagnostic devices to assess vascular health at the point of care. Therapeutic interventions can then be instituted and clinical progress quantified. Cardiology Institute of America collects data for several major nutraceuticals and biomedical supplement companies. https://www.cardiologyinstituteofamerica.com/
Advanced Medical Solutions International (AMSI) has advanced detection technology that can provide non-touch no-blood no-pain determinations of a patients’s blood glucose level. Mariamtek is helping AMSI with funding and product development.https://us-amsi.com/index.php/team-amsi/
Healthy Habitat
MaxClean 756 - MariamTek has purchased a strong equity position in this new company dedicated to environmental hygiene. Their proprietary air purification system provides for pathogen-free homes, schools, offices, hotels, cruise ships, hospitals, etc. https://maxclean756.com/
iLamp from ConFlow Power - is a green answer to the need for electrical power These autonomous self-charging street lights are free from the power grid and provide reliable street lighting for cities and citizens in any climate condition. Both of these entities are already listed on ILOCX. MariamTek uses its extensive global connections to secure license agreements for this technology for all regions especially in the Middle East, South Asia and Africa
i4TeKNow is a new MariamTek partnership in the field of printed electronics. We have joined forces with the founder of i4Techno, Dr Umer Salem, based in Kerala India, is an inventor and pioneer in this exciting new field of electronics that is less expensive and kinder to the environment. Professor Salem is passionate about remaining at the vanguard of this futuristic science with prototyping and design work, manufacturing joint ventures and educating the next generation of engineers. MariamTek has established the corporate entity in the US as i4TeKNow to facilitate the corporate expansion of Dr Salem’s technology in all corners of the world. https://i4techno.com/
Heather is a new entity under development to replace the use of petroleum in textile manufacturing and to provide a Habitat Healthy Leather alternative that does not use any toxic chemicals, petroleum or animal products. Natural Fiber Welding (NFW) the US-based inventor and supplier of these 100% compostable materials that are already are being incorporated into bags, shoes and apparel by name brand design houses and interiors for luxury automobiles. Heather is envisioned as a joint venture between MariamTek, NFW and regional businesses that want to bring this technology and manufacturing into South Asia where the raw materials are plentiful, the labor force is capable and the consumer base is nearly endless. https://www.naturalfiberwelding.com
Our strategy at MariamTek
MariamTek finds profitable solutions for the biggest problems in healthcare and the environment. We help these solutions reach the market by partnering with a combination of cash flow positive and near-profitable companies. We share the revenue with our licensees and devote a substantial portion of our remaining revenue to help develop promising new mid-stage technology that needs 3-5 years to reach the market.
Through innovative financial planning, MariamTek has the potential to generate immediate revenue streams for our licensees. In addition, our ILO provides the funding required for the maturation of the next generation of blockbuster technologies.
The technology startups we work with have:
1) The potential for large returns
2) Transformative or disruptive solution
3) A platform technology with multiple applications
4) A short development time
5) A well demarcated regulatory pathway
6) A strong intellectual property position
7) Demonstrated safety
Additionally, we look at the global market potential including opportunities for regional manufacturing and distribution, recruitment of key opinion leaders among physicians, business people and government ministers. If the solution is related to healthcare, it ideally is a natural product (already in our bodies or in nature), be stable & easily transportable, while remaining affordable for all citizens.
The technology startups we work with ideally have the potential for large returns, a transformative or disruptive solution, a platform technology with multiple applications, a short development time, a well demarcated regulatory pathway, a strong intellectual property position and demonstrated safety.
Meeting our revenue goals therefore keeps our licensees happy because:
1) Licensees share in the annual revenue
2) They benefit from MariamTek’s expanding equity portfolio
3) License values increase for greater ROI and liquidity
4) Have access to discounts on future ILO launches
.jpg)
MariamTek is proud to announce the launch of Diabetes Actual
Diabetes Actual is a MariamTek spin-off seeking to restore metabolic wellness for diabetes patients around the world. We use clinically proven therapies to reverse the ravages of diabetes by restoring insulin sensitivity. This is made possible through partnership with the US-based company that developed this revolutionary treatment, Well Cell Global. Diabetes Actual seeks to deploy their FDA-approved, life-saving technology throughout the world. We have established a partnership with WellCell Global to distribute this diabetes care technology into the GCC and Asia. Existing licensees of MariamTek can qualify for a discount on the purchase of DiabetesActual licenses or exchange some of all of their MariamTek licenses for licenses in DiabetesActual. MariamTek is dedicated to advancing the care of diabetics including better, less expensive, safer pain free glucose monitoring technologies. We are also actively pursuing technologies and new scientific discoveries that can turn back the ravages of diabetes and restore insulin production.
Diabetes Actual’s pulsatile insulin protocol restores insulin sensitivity to cells, helping to ensure that maximal energy is generated. The results are decreased problems from the complications of diabetes including heart disease, stroke, neuropathy, Alzheimer’s, kidney function, erectile dysfunction, wound healing and amputations.
Diabetes Actual is licensing partnerships with regional distributors in the US, the Asia Pacific and GCC countries. Furthermore, there is a clinic treating patients and generating revenue in Chicago and plans are well underway to partner with WellCell Global in deploying this life- and limb-saving protocol in the GCC and India.
.jpg)
HEALTHCARE
We work with a variety of healthcare solutions, with a focus on prevention, treatment and restoration. These cover a range of sectors, including infectious disease, diabetes, atherosclerosis, cancer, tissue damage and aging/dementia. Examples of our technology discoveries include:
1) Pain-free micro-needle vaccination technology that provides an easy way to vaccinate the world at 1/10th the cost without cold chain dependency.
2) Our trauma treatment sector features solutions for the global blood bank shortage. Our LifePak is a blood bank in a backpack containing platelets and red blood cell substitutes. This highly portable kit is designed for trauma resuscitation at the scene of injury or in smaller rural hospitals and clinics. There’s no need for blood typing, refrigeration or technicians – helping to save lives.
3) The MG53 natural “molecular bandage” from Axolo repairs injury to cells, which preserves organs and saves lives. This has endless clinical uses such as for stroke, heart attacks, kidney failure, liver damage, lung damage, aging, ALS etc.
4) Pain control with a new non-opioid, first-in-class pharmaceutical agent from Cytometix. This product has an excellent safety profile, is non-addicting with few if any side effects. It controls pain on par with narcotics. The product can be administered via IV and oral routes and has significant anti-inflammatory effects. MariamTek is helping to raise funds for Cytometix to complete their regulatory studies to get to the market.
5) Natural melanin for a planet healthy sunscreen. Current sunscreens and cosmetic colorants contain harmful chemicals that can be toxic to humans and to coral reefs. Avisa Myko has patented a technique to extract large quantities of natural melanin from a marine organism. Their solution produces large quantities of natural melanin at 1/100th of the cost of current methods. This enables the addition of natural melanin into a wide range of products ranging from cosmetics (e.g. sunscreen, hair colorants) to medical applications (protection from radiation exposure) to aerospace (effective and light-weight shielding from cosmic radiation). MariamTek hopes to launch Avisa Myko on their own ILOCX platform this year.
6) Non-invasive, non-touch rapid diagnostics for viral infection (including Covid) and realtime blood glucose monitoring. The miniaturization of Hybrid Infrared Radio Frequency (HIRF) technology allows for the development of detection devices that can scan the body for many different proteins and chemicals. MariamTek is working with American Medical Solutions International (AMSI) based in Florida, USA. AMSI has developed the Covid Hunter™ and produced a prototype that determines your blood sugar level with a simple non touch scanning of your skin.
.jpg)
ENVIRONMENT
MariamTek has a range of environmental partners with solutions to help mitigate the negative effects of petroleum-based plastics and polyester. One of our key partners, Natural Fiber Welding (NFW), has developed a new circular chemical process that adds amazing strength and functionality to plant-based cellulose fibers.
This technology replaces the need for petroleum-based plastics and yarn and will transform the multi-trillion textile, leather-goods, shoe, luggage and furnishing industries. This results in products that are 100% recyclable or compostable. NFW’s technology unlocks the power of plants and supports their rallying cry, “Plants, Not Plastics™.
NFW has already received investment and/or formed partnerships with major fashion producers of polo shirts, shoes and luxury interiors for high end car makers. MariamTek is introducing NFW’s technology to various regions of the world through the supply of their eco-friendly materials to designers, artisans and manufacturers. MariamTek’s newest entity, Heather, Ltd. will supply Habitat Healthy Leather to India and the rest of Asia.
MariamTek has launched Heather, Ltd. to import and distribute NFW’s Mirum brand of plant-based leather that is 100% recyclable, has 0% petroleum content and handles and feels like animal skin leather.
The technology startups we work with ideally have the potential for large returns, a transformative or disruptive solution, a platform technology with multiple applications, a short development time, a well demarcated regulatory pathway, a strong intellectual property position and demonstrated safety.
Additionally we look at the global market potential including opportunities for regional manufacturing and distribution, recruitment of key opinion leaders among physicians, business people and government ministers. If the solution is related to healthcare, it ideally is a natural product (already in our bodies), be stable & easily transportable, while remaining affordable for all citizens.
Company Name
MARIAMTEK, INC.COMPANY NUMBER
7155608STATUS
ACTIVEINCORPORATION DATE
11/19/2018COMPANY TYPE
CorporationJURISDICTION
DELAWARE, United statesREGISTRY PAGE
Division of Corporations, Delaware.jpg)
Dr Holterman is the founder of the Mariam Group which is a philanthropic organization dedicated to improving life on the planet with solutions to the most vexing problems affecting health, habitat and human development. MariamTek is the for-profit operational arm, which finds and develops transformative and far-reaching solutions on a global scale.
His experience as a practicing physician-surgeon and research scientist enables him to identify and verify solutions to a variety of problems, particularly in the healthcare field. When it comes to Diabetes Actual, Dr Holterman deploys the same technologies in his own clinic with good success and happy patients.
Trupti Parikh is a pediatric nurse practitioner with 20 years of experience in healthcare, including direct patient nursing and administration. She is dedicated to the mission of global health and the goal of healthy functional aging, and currently serves as the Director of Clinical Development for Diabetes Actual.
Ravindra is a serial entrepreneur specializing in IT and education is based in India and the UAE. He is a partner and founding member of MariamTek and the Mariam Group. He brings his business experience and global connectivity to the development and deployment of Diabetes Actual protocols to the world.
Royalty Percent
10%
Licenses Issued
50,000
Qualification
Confirmed share to your network, either via social media, group chat or other outreach.
Reserve Territory Now
Global licensing will allow people to expand products or services into new territories.
Cost to reserve
Claim your territory to earn more benefits.
100,000
TERMS
- Must hold licenses to keep option
- View Option Agreement
- Standard royalty license agreement and buyer terms